ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

MRKR Marker Therapeutics Inc

4.05
0.00 (0.00%)
시간외 단일가
최종 업데이트: 22:00:02
15분 지연
기업명 주식 심볼 시장 주식 타입
Marker Therapeutics Inc MRKR 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
0.00 0.00% 4.05 22:00:02
개장가 저가 고가 종가 전일 종가
4.05
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
08/04/202420:00GLOBEPrincipal Investigator from City of Hope National Medical..
26/03/202406:45GLOBEMarker Therapeutics Reports Year-End 2023 Corporate and..
23/03/202401:30GLOBEMarker Therapeutics to Present at the H.C. Wainwright 2nd..
01/03/202422:02EDGAR2Form 8-K - Current report
26/02/202421:58EDGAR2Form 8-K - Current report
22/01/202421:30GLOBEMarker Therapeutics Receives Approval from United States..
08/01/202422:30EDGAR2Form 8-K - Current report
08/01/202422:24GLOBEMarker Therapeutics Announces Clinical Program Updates and..
22/12/202301:00GLOBEMarker Therapeutics Announces Participation in Biotech..
11/12/202321:35EDGAR2Form 8-K - Current report
11/12/202321:00GLOBEMarker Therapeutics Announces Sustained Complete Response in..
21/11/202306:37EDGAR2Form 8-K - Current report
10/11/202307:03EDGAR2Form 8-K - Current report
10/11/202307:00GLOBEMarker Therapeutics Reports Third Quarter 2023 Financial..
10/11/202306:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
11/09/202320:10EDGAR2Form 8-K - Current report
11/09/202320:00GLOBEMarker Therapeutics Announces Complete Response in First..
30/08/202321:00GLOBEMarker Therapeutics to Present at the H.C. Wainwright 25th..
15/08/202305:37EDGAR2Form 8-K - Current report
15/08/202305:30GLOBEMarker Therapeutics Reports Second Quarter 2023 Financial..
15/08/202305:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/08/202320:22EDGAR2Form 8-K - Current report
07/08/202320:00GLOBEMarker Therapeutics Reports Non-Clinical Proof-of-Concept..
26/07/202320:00GLOBEMarker Therapeutics to Participate in Virtual Roundtable..
10/07/202320:09EDGAR2Form 8-K - Current report
10/07/202320:00GLOBEEuropean Medicines Agency Grants Orphan Drug Designation for..
06/07/202305:22EDGAR2Form 3 - Initial statement of beneficial ownership of..
04/07/202305:05EDGAR2Form 8-K - Current report
01/07/202305:05EDGAR2Form 8-K - Current report
26/06/202320:00GLOBEMarker Therapeutics Reports MT-401 Non-Clinical Data in AML..
12/06/202320:00GLOBEMarker Therapeutics Announces First Lymphoma Patient Treated..
31/05/202319:30GLOBEMarker Therapeutics Reports Pre-Clinical Data of its MT-601..
08/05/202320:30GLOBEMarker Therapeutics Appoints Monic Stuart, M.D., as Chief..

최근 히스토리

Delayed Upgrade Clock